Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Bookmark
Array Biopharma Inc. has a market cap of $182.6 million; its shares were traded at around $3.61 with and P/S ratio of 7.3. Array Biopharma Inc. had an annual average earning growth of 26.3% over the past 10 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jim Simons of Renaissance Technologies LLC.
CFO Recent Trades:
- Sell:: CFO Michael Carruthers sold 1,074 shares of ARRY stock on 04/23/2010 at the average price of 3.78, the price of the stock has decreased by 4.5% since.
- Sell:: CFO Michael Carruthers sold 1,661 shares of ARRY stock on 03/23/2010 at the average price of 2.46, the price of the stock has increased by 46.75% since.
- Sell:: CFO Michael Carruthers sold 1,707 shares of ARRY stock on 02/23/2010 at the average price of 2.4, the price of the stock has increased by 50.42% since.
- Sell:: CFO Michael Carruthers sold 6,286 shares of ARRY stock on 02/05/2010 at the average price of 2.44, the price of the stock has increased by 47.95% since.
- Sell:: CFO Michael Carruthers sold 1,644 shares of ARRY stock on 01/22/2010 at the average price of 2.49, the price of the stock has increased by 44.98% since.
This is the insider trade history vs. stock price of ARRY. For the complete insider trading history of ARRY, click here.
Directors and Officers Recent Trades:
- Buy:: Director Kyle Lefkoff bought 4,000 shares of ARRY stock on 05/07/2010 at the average price of 3.71, the price of the stock has decreased by 2.7% since.
Subscribe RSS
RSS